NORWICH VENTURES

Thesis

Norwich Ventures is a venture capital firm established in 2004, headquartered in Waltham, Massachusetts. The firm focuses on early-stage investments in the medical technology (medtech) sector, seeking to back entrepreneurs developing innovative solutions for critical unmet medical needs. Their investment strategy targets 'best-in-class' medtech companies that exhibit capital-efficient business models, possess clear barriers to entry, and have a swift route to proof of concept. Norwich Ventures is sector-agnostic within medtech, exploring opportunities across diverse fields like electrophysiology, genomics, and women's health, provided the new technologies offer substantial clinical value. They primarily invest in seed and pre-seed rounds, adopting a long-term investment horizon. While specific check sizes are not publicly disclosed, typical early-stage investments range from several hundred thousand to a few million dollars. The firm concentrates on companies based in the United States, with a particular interest in the New England and Mid-Atlantic regions, although they are open to investments elsewhere. Norwich Ventures manages a fund size of $90 million (Medtech Convergence Fund, closed April 2023), with other sources indicating a latest fund size of $650 million and total AUM of $4.2 billion. The firm is actively seeking new investment opportunities.

Related lists

• Pre-seed Healthcare investors
• Seed-stage Healthcare investors
• Series A Healthcare investors